Contraceptive Vaccine
Review focused on recent advances in contraceptive vaccine development
Published in Vaccine Weekly, February 1st, 2006
According to a report from the United States and India, "Contraceptive vaccines (CV) may provide viable and valuable alternatives to the presently available methods of contraception. The molecules that are being explored for CV development either target gamete production [luteinizing hormone-releasing hormone (LHRH)/GnRH, FSH], gamete function [sperm antigens and oocyte zona pellucida (ZP)], and gamete outcome (HCG). CV targeting gamete production have shown varied degrees of efficacy; however, they either affect sex steroids causing impotency and/or show only...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Vaccine Weekly
Source: Vaccine Weekly (2006-02-01)
More Articles from Vaccine Weekly
- DPT Vaccines
A CpG-containing oligodeoxynucleotide is an efficient diphtheria-tetanus-pertussis vaccine adjuvant - SARS Vaccine
Equine hyperimmune globulin F(Ab')2 shows promise against SARS coronavirus - Smallpox Vaccine
Diversity is found in acute CD8 T cell response to vaccinia virus - Adenovirus Vector
Method is developed to deliver adenovirus formulation to the lung - Adverse Events
Mouse study suggests a risk of serious side effects with peptide vaccines - Allergy & Immunology
Anthroposophic lifestyle reduces risk of allergic disease in children - More from this issue of Vaccine Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
